| # | Drug | Count |
|---|---|---|
| 0 | OLANZAPINE | 6 |
| 1 | MORPHINE SULFATE | 5 |
| 2 | OLANZAPINE PAMOATE | 5 |
| 3 | QUETIAPINE | 5 |
| 4 | BUPROPION HYDROCHLORIDE | 4 |
| 5 | CLOZAPINE | 4 |
| 6 | METHOTREXATE SODIUM | 4 |
| 7 | TACROLIMUS | 4 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 4 |
| 9 | TACROLIMUS OINTMENT 0.1% | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION, 0.02%/0.005% | 1 | 0.0010 |
| 1 | METHYLPHENIDATE HCL | 1 | 0.0008 |
| 2 | CODEINE SULFATE | 2 | 0.0006 |
| 3 | SALICYLIC ACID 12% | 1 | 0.0005 |
| 4 | ASTRINGENT | 1 | 0.0005 |
| 5 | LIQUID CORN AND CALLUS REMOVER | 1 | 0.0005 |
| 6 | PERPHENAZINE | 1 | 0.0005 |
| 7 | MARIBAVIR | 1 | 0.0004 |
| 8 | ESLICARBAZEPINE ACETATE | 1 | 0.0003 |
| 9 | ASCIMINIB | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 12 |
| 1 | Benzodiazepine [EPC] | 9 |
| 2 | Corticosteroid [EPC] | 5 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 4 | Anti-epileptic Agent [EPC] | 4 |
| 5 | Opioid Agonist [EPC] | 4 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 3 |
| 7 | Alkaloid [EPC] | 2 |
| 8 | Fluoroquinolone Antibacterial [EPC] | 2 |
| 9 | Kinase Inhibitor [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Alkaloid [EPC] | 2 | 0.0001 |
| 4 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 5 | Non-Standardized Plant Allergenic Extract [EPC] | 1 | 0.0001 |
| 6 | Macrolide Antimicrobial [EPC] | 2 | 0.0000 |
| 7 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 8 | Phenothiazine [EPC] | 1 | 0.0000 |
| 9 | Atypical Antipsychotic [EPC] | 12 | 0.0000 |